ESC 365 - The interplay between left ventricular function and diffuse fibrosis in patients with atrial fibrillation undergoing ablation: insights from a prospective longitudinal cardiac magnetic resonance study

ESC Premium Access

The interplay between left ventricular function and diffuse fibrosis in patients with atrial fibrillation undergoing ablation: insights from a prospective longitudinal cardiac magnetic resonance study

Session: Advances in ablation for atrial fibrillation

Topic: Atrial fibrillation (AF)

Speaker: Doctor R. Wijesurendra (Oxford, GB)

Event: ESC Congress 2017

Congress Presentation

About the speaker

Doctor Rohan Wijesurendra

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

5 presentations

0 follower

4 more presentations in this session

State of the Art: when, who and how of atrial fibrillation ablation

Speaker: Doctor C. Piorkowski (Dresden, DE)

Very long-term outcome following transcatheter ablation of atrial fibrillation. Are results maintained after 10 years of follow up?

Speaker: Doctor A. Battaglia (Asti, IT)

Critical role of non-pulmonary vein triggers in patients with atrial fibrillation referred after two or more failed catheter ablations

Speaker: Doctor S. Mohanty (Austin, US)

Ablation for atrial fibrillation: can we do any better?

Speaker: Professor L. Di Biase (The Bronx, US)

Access the full session

Advances in ablation for atrial fibrillation

Speakers: Doctor R. Wijesurendra, Doctor C. Piorkowski, Doctor A. Battaglia, Doctor S. Mohanty, Professor L. Di Biase

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

Related content

ESC Premium Access

Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation

27 August 2021

ESC Premium Access

Case report on a transthyretin-related amyloidosis caused by Leu32Val mutation and its interdisciplinary challenge.

27 August 2021

ESC Premium Access

A case of cardiac amyloidosis initially mis-diagnosed as BRASH syndrome.

27 August 2021

ESC 365 is supported by